AB
TCRT icon

Amalgamated Bank’s Alaunos Therapeutics TCRT Stock Holding History

Amalgamated Bank’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-228
Closed -$22K – 3194
2022
Q1 		$22K Sell
228
-19
-8% -$2.44K ﹤0.01% 2783
2021
Q4 		$40K Sell
247
-7
-3% -$1.54K ﹤0.01% 2119
2021
Q3 		$69K Sell
254
-10
-4% -$3.06K ﹤0.01% 2112
2021
Q2 		$105K Buy
264
+76
+40% +$35.5K ﹤0.01% 2117
2021
Q1 		$101K Hold
188
– – ﹤0.01% 1554
2020
Q4 		$71K Buy
188
+1
+0.5% +$398 ﹤0.01% 1543
2020
Q3 		$71K Sell
187
-4
-2% -$1.77K ﹤0.01% 1435
2020
Q2 		$94K Buy
191
+1
+0.5% +$446 ﹤0.01% 1404
2020
Q1 		$70K Buy
190
+1
+0.5% +$517 ﹤0.01% 1534
2019
Q4 		$134K Hold
189
– – ﹤0.01% 1699
2019
Q3 		$122K Sell
189
-2
-1% -$1.59K ﹤0.01% 1632
2019
Q2 		$167K Buy
191
+54
+39% +$37.1K ﹤0.01% 1625
2019
Q1 		$79K Buy
137
+4
+3% +$1.67K ﹤0.01% 1614
2018
Q4 		$37K Buy
+133
New +$52.6K ﹤0.01% 1585
2018
Q3 		– Sell
-133
Closed -$60K – 1609
2018
Q2 		$60K Buy
133
+15
+13% +$9.51K ﹤0.01% 1689
2018
Q1 		$69K Sell
118
-2
-2% -$1.25K ﹤0.01% 1551
2017
Q4 		$74K Buy
120
+9
+8% +$6.47K ﹤0.01% 1588
2017
Q3 		$102K Sell
111
-1
-0.9% -$888 ﹤0.01% 1512
2017
Q2 		$105K Buy
112
+13
+13% +$12.7K ﹤0.01% 1512
2017
Q1 		$94K Hold
99
– – ﹤0.01% 1447
2016
Q4 		$80K Buy
99
+13
+15% +$11.7K ﹤0.01% 1467
2016
Q3 		$73K Hold
86
– – ﹤0.01% 1351
2016
Q2 		$67K Buy
86
+6
+8% +$6.53K ﹤0.01% 1347
2016
Q1 		$90K Buy
80
+7
+10% +$7.16K 0.01% 1232
2015
Q4 		$92K Sell
73
-7
-9% -$11.6K 0.01% 1149
2015
Q3 		$109K Buy
80
+1
+1% +$1.65K 0.01% 1229
2015
Q2 		$142K Buy
+79
New +$123K 0.01% 1286

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Amalgamated Bank's TCRT Position: Q2 2022 in Review

Amalgamated Bank sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 228 shares — an estimated $22K sold.

Amalgamated Bank first reported a position in TCRT in Q2 2015 and held it in 27 quarters. The position peaked at $167K in Q2 2019. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.

  • Amalgamated Bank reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 228 Alaunos Therapeutics shares in Q2 2022, an estimated $22K.
  • Amalgamated Bank first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 27 quarters.
  • Amalgamated Bank's Alaunos Therapeutics position peaked at $167K in Q2 2019.
  • 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.